YTHDF2 can regulate serpin family E member 2 (SERPINE2), interleukin 11 (IL11)decay, and vascular abnormalities in HCC, and inhibits the malignant progression of HCC (Hou et al., 2019). Here, IL11 is linked to hepatocellular carcinoma.